Results
|
101.
|
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. [electronic resource] by
- Amin, H M
- Yang, Y
- Shen, Y
- Estey, E H
- Giles, F J
- Pierce, S A
- Kantarjian, H M
- O'Brien, S M
- Jilani, I
- Albitar, M
Producer: 20051020
In:
Leukemia vol. 19
Availability: No items available.
|
|
102.
|
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance. [electronic resource] by
- Ravandi, F
- Kantarjian, H M
- Talpaz, M
- O'Brien, S
- Faderl, S
- Giles, F J
- Thomas, D
- Cortes, J
- Andreeff, M
- Estrov, Z
- Rios, M B
- Albitar, M
Producer: 20010628
In:
Cancer vol. 91
Availability: No items available.
|
|
103.
|
Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia. [electronic resource] by
- Weinkauff, R
- Estey, E H
- Starostik, P
- Hayes, K
- Huh, Y O
- Hirsch-Ginsberg, C
- Andreeff, M
- Keating, M
- Kantarjian, H M
- Freireich, E J
- Albitar, M
Producer: 19990616
In:
American journal of clinical pathology vol. 111
Availability: No items available.
|
|
104.
|
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. [electronic resource] by
- Lancet, J E
- Gojo, I
- Burton, M
- Quinn, M
- Tighe, S M
- Kersey, K
- Zhong, Z
- Albitar, M X
- Bhalla, K
- Hannah, A L
- Baer, M R
Producer: 20100520
In:
Leukemia vol. 24
Availability: No items available.
|
|
105.
|
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia. [electronic resource] by
- Jilani, I
- Wei, C
- Bekele, B N
- Zhang, Z J
- Keating, M
- Wierda, W
- Ferrajoli, A
- Estrov, Z
- Kantarjian, H
- O'Brien, S M
- Giles, F J
- Albitar, M
Producer: 20090313
In:
International journal of laboratory hematology vol. 31
Availability: No items available.
|
|
106.
|
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. [electronic resource] by
- Dabaja, B S
- O'Brien, S M
- Kantarjian, H M
- Cortes, J E
- Thomas, D A
- Albitar, M
- Schlette, E S
- Faderl, S
- Sarris, A
- Keating, M J
- Giles, F J
Producer: 20020116
In:
Leukemia & lymphoma vol. 42
Availability: No items available.
|
|
107.
|
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia. [electronic resource] by
- Faderl, S
- Kantarjian, H M
- Estey, E
- Manshouri, T
- Chan, C Y
- Rahman Elsaied, A
- Kornblau, S M
- Cortes, J
- Thomas, D A
- Pierce, S
- Keating, M J
- Estrov, Z
- Albitar, M
Producer: 20001121
In:
Cancer vol. 89
Availability: No items available.
|
|
108.
|
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. [electronic resource] by
- Khouri, I F
- Lee, M S
- Romaguera, J
- Mirza, N
- Kantarjian, H
- Korbling, M
- Albitar, M
- Giralt, S
- Samuels, B
- Anderlini, P
- Rodriguez, J
- von Wolff, B
- Gajewski, J
- Cabanillas, F
- Champlin, R
Producer: 20000210
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 10
Availability: No items available.
|
|
109.
|
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. [electronic resource] by
- Tsimberidou, A-M
- Kantarjian, H M
- Estey, E
- Cortes, J E
- Verstovsek, S
- Faderl, S
- Thomas, D A
- Garcia-Manero, G
- Ferrajoli, A
- Manning, J T
- Keating, M J
- Albitar, M
- O'Brien, S
- Giles, F J
Producer: 20030708
In:
Leukemia vol. 17
Availability: No items available.
|
|
110.
|
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. [electronic resource] by
- Giralt, S
- Estey, E
- Albitar, M
- van Besien, K
- Rondón, G
- Anderlini, P
- O'Brien, S
- Khouri, I
- Gajewski, J
- Mehra, R
- Claxton, D
- Andersson, B
- Beran, M
- Przepiorka, D
- Koller, C
- Kornblau, S
- Kørbling, M
- Keating, M
- Kantarjian, H
- Champlin, R
Producer: 19970710
In:
Blood vol. 89
Availability: No items available.
|
|
111.
|
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. [electronic resource] by
- Potts, B C
- Albitar, M X
- Anderson, K C
- Baritaki, S
- Berkers, C
- Bonavida, B
- Chandra, J
- Chauhan, D
- Cusack, J C
- Fenical, W
- Ghobrial, I M
- Groll, M
- Jensen, P R
- Lam, K S
- Lloyd, G K
- McBride, W
- McConkey, D J
- Miller, C P
- Neuteboom, S T C
- Oki, Y
- Ovaa, H
- Pajonk, F
- Richardson, P G
- Roccaro, A M
- Sloss, C M
- Spear, M A
- Valashi, E
- Younes, A
- Palladino, M A
Producer: 20110707
In:
Current cancer drug targets vol. 11
Availability: No items available.
|